Clinical Trial: Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07697196) titled 'Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration' on June 23.

Brief Summary: This interventional, single-center, open-label randomized clinical study evaluates the efficacy of an oral dietary supplement (Pervistop(R)) in women with persistent Human Papillomavirus (HPV) infection. The supplement is a combination of four natural molecules: Epigallocatechin gallate (EGCG), folic acid (FA), vitamin B12 (B12), and hyaluronic acid (HA).The primary objective is to describe the effect of this association on HPV DNA integration into the host genome by measuring the clearance rate of viral oncoproteins E6 and...